Approval · Notice of Compliance 26271 · 2021
OSPHENA: Notice of Compliance 26271
Issued July 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26271
- Date
- July 16, 2021
- Company
- Duchesnay Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OSPHENA | 02518112 | Marketed |
Medicinal ingredients
- OSPEMIFENE 60 MG per TAB